Education
About Us
Working with TipRanks
Follow Us
Affymax (AFFY)
OTHER OTC:AFFY
AFFY Stock Chart & Stats
<$0.01
<$0.01(200.00%)
At close: 4:00 PM EST
<$0.01
<$0.01(200.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.04
Previous CloseN/A
Volume1.50K
Average Volume (3M)N/A
Market Cap
$33.74K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-5.93
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
Dec 24, 2014Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding37,490,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
AFFY FAQ
What was Affymax’s price range in the past 12 months?
Affymax lowest stock price was <$0.01 and its highest was $0.04 in the past 12 months.
What is Affymax’s market cap?
Affymax’s market cap is $33.74K.
When is Affymax’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Affymax’s earnings last quarter?
Currently, no data Available
Is Affymax overvalued?
According to Wall Street analysts Affymax’s price is currently Overvalued.
Does Affymax pay dividends?
Affymax pays a Monthly dividend of $0.05 which represents an annual dividend yield of N/A. See more information on Affymax dividends here
What is Affymax’s EPS estimate?
Affymax’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Affymax have?
Affymax has 37,490,000 shares outstanding.
What happened to Affymax’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Affymax?
Currently, no hedge funds are holding shares in AFFY
Company Description
Affymax
Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.
Scinai Immunotherapeutics
―
Artelo Biosciences
―
PainReform
―
Dermata Therapeutics
―
Virax Biolabs Group Ltd. Class A
―
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---